AIM
Axiom Investment Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.36M | Buy |
8,386
+1,023
| +14% | +$165K | 3.53% | 6 |
|
|
2022
Q3 | $988K | Buy |
7,363
+23
| +0.3% | +$3.09K | 1.97% | 9 |
|
|
2022
Q2 | $1.12M | Buy |
7,340
+21
| +0.3% | +$3.22K | 3.23% | 6 |
|
|
2022
Q1 | $1.19M | Sell |
7,319
-410
| -5% | -$66.4K | 2.58% | 9 |
|
|
2021
Q4 | $1.05M | Sell |
7,729
-725
| -9% | -$98.2K | 1.01% | 21 |
|
|
2021
Q3 | $912K | Buy |
8,454
+26
| +0.3% | +$2.81K | 0.92% | 24 |
|
|
2021
Q2 | $949K | Sell |
8,428
-4,475
| -35% | -$504K | 0.74% | 38 |
|
|
2021
Q1 | $1.4M | Buy |
12,903
+12,368
| +2,312% | +$1.34M | 1.14% | 17 |
|
|
2020
Q4 | $480 | Sell |
535
-9,065
| -94% | -$8.13K | 0.44% | 54 |
|
|
2020
Q3 | $841K | Sell |
9,600
-317
| -3% | -$27.8K | 0.95% | 29 |
|
|
2020
Q2 | $974K | Buy |
9,917
+5,286
| +114% | +$519K | 1.29% | 23 |
|
|
2020
Q1 | $353K | Sell |
4,631
-43
| -0.9% | -$3.28K | 0.62% | 50 |
|
|
2019
Q4 | $414K | Sell |
4,674
-13,105
| -74% | -$1.16M | 0.59% | 54 |
|
|
2019
Q3 | $1.35M | Sell |
17,779
-36,521
| -67% | -$2.78M | 1.03% | 26 |
|
|
2019
Q2 | $3.97M | Buy |
54,300
+1,882
| +4% | +$137K | 0.72% | 32 |
|
|
2019
Q1 | $4.22M | Buy |
52,418
+2,959
| +6% | +$238K | 0.8% | 28 |
|
|
2018
Q4 | $4.56M | Buy |
+49,459
| New | +$4.56M | 0.96% | 25 |
|